The ingredient Dr. Park uses to "wake up" that repair signal is called PDRN — Polydeoxyribonucleotide. It's barely known in Western dermatology, which surprised me, because in Korea it's been a clinical gold standard for over fifty years — used for deep tissue recovery, wound healing, and skin regeneration. Dongkook Pharmaceutical has been refining it since 1968.

Unlike the actives I'd been prescribing for years, PDRN doesn't sit on the surface. It activates specific receptors deep in the dermis — the skin's living repair layer — and signals the body to rebuild the barrier on its own. It's not another exfoliant, and it's not another retinoid. It's the step that comes before either of those can safely do their job.

"The reason most doctors don't reach for it," Dr. Park told me, "is that the market makes more money selling a new surface product every season than teaching a patient to repair the layer underneath — once."

I asked her the question every dermatologist would ask: isn't a clinical treatment stronger than a cream? "A cream isn't an injection," she said, "and it doesn't need to be. The repair layer's only job is to rebuild the foundation. Get that right, and the retinol your patient is already using finally has something to work on instead of something to fight."

That reframed everything I'd been telling patients. It was never one step. First you repair — that's PDRN, at 20,000 ppm, rebuilding the barrier and waking the signal. Then you reverse — that's TECA, at 30,000 ppm, the renewal layer that lets retinol finally do what it was always supposed to do, without tearing the skin apart to get there. Repair first. Reverse second. The order is everything.